Melamine: Scoping Review Reveals Potential Endocrine, Reproductive, and Neurotoxic Activities
1:00 pm US Eastern Time
Bolden, Ashley L, et al. Melamine, beyond the kidney: A ubiquitous endocrine disruptor and neurotoxicant? Toxicology Letters. October 5, 2017.
Melamine is an ingredient frequently used in a variety of consumer products including furniture, diningware, food utensils, and flooring. The results of a recent scoping review completed by The Endocrine Disruption Exchange suggest that melamine exposure may contribute to health effects beyond renal dysfunction, including neurological, reproductive, and anthropometric impacts. This presentation discussed the results of the study and demonstrated how scoping reviews can assist systematic reviewers in identifying feasible and relevant research questions.
Ashley L. Bolden, MS is a Senior Scientist with The Endocrine Disruption Exchange. She utilizes systematic review procedures to evaluate scientific evidence that relates exposures to a wide variety of endocrine disrupting chemicals with health outcomes throughout all stages of the lifespan. Currently she and her colleagues are evaluating the evidence streams of several chemicals and health effects. Projects include assessment of the reproductive, developmental, and endocrine research on triclocarban exposure, early life environmental chemical exposure and autism, and air pollutants associated with unconventional oil and gas production with potential endocrine activity.
Prior to working at The Endocrine Disruption Exchange Ms. Bolden studied immune response in the brain following closed head traumatic injury. In graduate school at the University of Colorado Boulder, she explored the impacts of waste-treated water on the reproductive behaviors and physiology in both wild and experimental fish models.
This webinar is one in a monthly series sponsored by the Collaborative on Health and the Environment’s EDC Strategies Partnership. The CHE EDC Strategies Partnership is chaired by Carol Kwiatkowski (TEDX), Sharyle Patton (Commonweal), and Genon Jensen (HEAL). To see a full list of past calls and webinars related to EDCs and listen or view recordings, please visit our partnerships page.
This webinar was moderated by Carol Kwiatkowski, PhD, Executive Director of The Endocrine Disruption Exchange. It lasted for 30 minutes and was recorded for our call and webinar archive.